Prévisions du marché des dispositifs de neurostimulation en Asie-Pacifique jusqu\'en 2030 – Analyse régionale – par produit (stimulateur de la moelle épinière, stimulateur cérébral profond, stimulateur du nerf sacré, stimulateur du nerf vague et autres), application (gestion de la douleur, épilepsie, incontinence urinaire et fécale, Parkinson) s, et autres) et utilisateur final (hôpitaux, cliniques spécialisées et autres)

Le marché des appareils de neurostimulation en Asie-Pacifique était évalué à 1 197,94 millions de dollars américains en 2022 et devrait atteindre 2 517,30 millions de dollars américains d’ici 2030 ; on estime qu’il enregistrera un TCAC de 9,7 % de 2022 à 2030. Les progrès croissants et les approbations des dispositifs de neurostimulation stimulent le marché des dispositifs de neurostimulation en Asie-Pacifique. Les fabricants investissent des sommes importantes dans le développement de produits et de technologies avancés tels que les dispositifs de neurostimulation implantables. De plus, une augmentation des approbations de la Food and Drug Administration (FDA) pour de nouveaux neurostimulateurs avec de nouvelles applications est observée sur le marché des appareils de neurostimulation. Voici quelques avancées et approbations pour les appareils de neurostimulation. En février 2021, Mainstay Medical a développé un système de neurostimulation réparatrice implantable, ReActiv8, pour traiter les lombalgies chroniques intraitables. En mars 2021, Abbott a lancé NeuroSphere, une clinique virtuelle conçue pour aider les patients soumis à une stimulation cérébrale profonde à programmer et à réinitialiser leurs appareils à distance dans le confort de leur foyer. En janvier 2021, Boston Scientific Corporation a lancé WaveWriter Alpha, une gamme de systèmes de stimulation de la moelle épinière (SCS) qui combinent des options thérapeutiques pour un soulagement personnalisé de la douleur. Par conséquent, le nombre croissant d’avancées et d’approbations pour les appareils de neurostimulation devrait offrir des opportunités lucratives pour le marché des appareils de neurostimulation au cours de la période de prévision. Aperçu du marché des appareils de neurostimulation en Asie-Pacifique Le marché des appareils de neurostimulation en Asie-Pacifique est sous-segmenté en Chine, au Japon, en Inde, en Australie, en Corée du Sud et dans le reste de l\'Asie-Pacifique. Le marché de la région Asie-Pacifique devrait connaître la croissance la plus rapide parmi toutes les régions. La prise de conscience croissante des troubles neurologiques dans des pays comme l’Inde, l’Australie et la Corée du Sud définit la croissance du marché dans la région. Le marché des dispositifs de neurostimulation en Asie-Pacifique devrait également croître en raison du développement croissant de l’industrie des dispositifs médicaux dans des pays comme le Japon et la Chine. En outre, les tendances technologiques innovantes en neurologie et l’adoption rapide de l’intelligence artificielle (IA) et de l’apprentissage automatique (ML) sont quelques facteurs qui stimulent le marché dans la région. En outre, les initiatives gouvernementales de soutien et la recherche en neurologie stimulent également la croissance du marché. Revenus et prévisions du marché des appareils de neurostimulation en Asie-Pacifique jusqu’en 2030 (en millions de dollars américains) Segmentation du marché des appareils de neurostimulation en Asie-Pacifique Le marché des appareils de neurostimulation en Asie-Pacifique est segmenté en fonction du produit, de l’application, de l’utilisateur final et du pays. En fonction du produit, le marché des appareils de neurostimulation en Asie-Pacifique est segmenté en stimulateur de la moelle épinière, stimulateur cérébral profond, stimulateur du nerf sacré, stimulateur du nerf vague et autres. Le segment des stimulateurs de la moelle épinière détenait la plus grande part de marché en 2022. En termes d’application, le marché des appareils de neurostimulation en Asie-Pacifique est classé en gestion de la douleur, épilepsie, incontinence urinaire et fécale, maladie de Parkinson et autres. Le segment de la gestion de la douleur détenait la plus grande part de marché en 2022. Par utilisateur final, le marché des appareils de neurostimulation en Asie-Pacifique est segmenté en hôpitaux, cliniques spécialisées et autres. Le segment des hôpitaux détenait la plus grande part de marché en 2022. En fonction des pays, le marché des appareils de neurostimulation en Asie-Pacifique est segmenté entre le Royaume-Uni, la Chine, le Japon, l’Inde, l’Australie, la Corée du Sud et le reste de l’Asie-Pacifique. La Chine a dominé la part de marché des appareils de neurostimulation en Asie-Pacifique en 2022. Medtronic Plc, Boston Scientific Corp, Abbott Laboratories, Nevro Corp, LivaNova Plc et Mainstay Medical font partie des principales sociétés opérant sur le marché des appareils de neurostimulation en Asie-Pacifique.

Table of Content

1. Introduction

1.1 The Insight Partners Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Neurostimulation Devices Market - Key Industry Dynamics

4.1 Market Drivers

4.1.1 Increasing Prevalence of Neurological Disorders

4.1.2 Rising Cases of Spinal Cord Injury

4.2 Market Restraints

4.2.1 Lack of Expert Professionals

4.3 Market Opportunities

4.3.1 Growing Advances and Approvals for Neurostimulation Devices

4.4 Future Trends

4.4.1 Rising Demand for Noninvasive Treatment

4.5 Impact Analysis

5. Neurostimulation Devices Market - Asia Pacific Market Analysis

5.1 Asia Pacific Neurostimulation Devices Market Revenue (US$ Mn), 2022 - 2030

6. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Product

6.1 Overview

6.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

6.3 Spinal Cord Stimulator

6.3.1 Overview

6.3.2 Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.4 Deep Brain Stimulator

6.4.1 Overview

6.4.2 Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.5 Sacral Nerve Stimulator

6.5.1 Overview

6.5.2 Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.6 Vagus Nerve Stimulator

6.6.1 Overview

6.6.2 Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

6.7 Others

6.7.1 Overview

6.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview

7.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

7.3 Pain Management

7.3.1 Overview

7.3.2 Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.4 Epilepsy

7.4.1 Overview

7.4.2 Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.5 Urinary and Fecal Incontinence

7.5.1 Overview

7.5.2 Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.6 Parkinson's Disease

7.6.1 Overview

7.6.2 Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

7.7 Others

7.7.1 Overview

7.7.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - by End User

8.1 Overview

8.2 Asia Pacific Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

8.3 Hospitals

8.3.1 Overview

8.3.2 Hospitals: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.4 Specialty Clinics

8.4.1 Overview

8.4.2 Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Neurostimulation Devices Market - Revenue and Forecast to 2030 - Country Analysis

9.1 Asia Pacific: Neurostimulation Devices Market

9.1.1 Overview

9.1.2 Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

9.1.2.1 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.2 China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.2.1 China: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.2.2 China: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.2.3 China: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.3 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.4 Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.4.1 Japan: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.4.2 Japan: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.4.3 Japan: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.5 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.6 India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.6.1 India: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.6.2 India: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.6.3 India: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.7 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.8 Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.8.1 Australia: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.8.2 Australia: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.8.3 Australia: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.9 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.10 South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.10.1 South Korea: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.10.2 South Korea: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.10.3 South Korea: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

9.1.2.11 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (USD Million)

9.1.2.12 Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

9.1.2.12.1 Rest of Asia Pacific: Neurostimulation Devices Market, by Product, 2020-2030 (US$ Million)

9.1.2.12.2 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2030 (US$ Million)

9.1.2.12.3 Rest of Asia Pacific: Neurostimulation Devices Market, by End User, 2020-2030 (US$ Million)

10. Neurostimulation Devices Market-Industry Landscape

10.1 Overview

10.2 Organic Developments

10.2.1 Overview

10.3 Inorganic Developments

10.3.1 Overview

11. Company Profiles

11.1 Medtronic Plc

11.1.1 Key Facts

11.1.2 Business Description

11.1.3 Products and Services

11.1.4 Financial Overview

11.1.5 SWOT Analysis

11.1.6 Key Developments

11.2 Boston Scientific Corp

11.2.1 Key Facts

11.2.2 Business Description

11.2.3 Products and Services

11.2.4 Financial Overview

11.2.5 SWOT Analysis

11.2.6 Key Developments

11.3 Abbott Laboratories

11.3.1 Key Facts

11.3.2 Business Description

11.3.3 Products and Services

11.3.4 Financial Overview

11.3.5 SWOT Analysis

11.3.6 Key Developments

11.4 Nevro Corp

11.4.1 Key Facts

11.4.2 Business Description

11.4.3 Products and Services

11.4.4 Financial Overview

11.4.5 SWOT Analysis

11.4.6 Key Developments

11.5 LivaNova Plc

11.5.1 Key Facts

11.5.2 Business Description

11.5.3 Products and Services

11.5.4 Financial Overview

11.5.5 SWOT Analysis

11.5.6 Key Developments

11.6 Mainstay Medical

11.6.1 Key Facts

11.6.2 Business Description

11.6.3 Products and Services

11.6.4 Financial Overview

11.6.5 SWOT Analysis

11.6.6 Key Developments

12. Appendix

12.1 About Us

12.2 Glossary of Terms

List of Tables

Table 1. Neurostimulation Devices Market Segmentation

Table 2. China Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 3. China Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 4. China Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 5. Japan Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 6. Japan Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 7. Japan Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 8. India Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 9. India Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 10. India Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 11. Australia Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 12. Australia Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 13. Australia Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 14. South Korea Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 15. South Korea Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 16. South Korea Neurostimulation Devices Market, by End User - Revenue and Forecast to 2030 (US$ Million)

Table 17. Rest of Asia Pacific Neurostimulation Devices Market, by Product - Revenue and Forecast to 2030 (US$ Million)

Table 18. Rest of Asia Pacific Neurostimulation Devices Market, by Application - Revenue and Forecast to 2030 (US$ Million)

Table 19. Rest of Asia Pacific Neurostimulation Devices Market, by End User- Revenue and Forecast to 2030 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms, Neurostimulation Devices Market

List of Figures

Figure 1. Neurostimulation Devices Market Segmentation, By Country

Figure 2. Neurostimulation Devices Market: Key Industry Dynamics

Figure 3. Neurostimulation Devices Market: Impact Analysis of Drivers and Restraints

Figure 4. Asia Pacific Neurostimulation Devices Market Revenue (US$ Mn), 2020 - 2030

Figure 5. Asia Pacific Neurostimulation Devices Market Revenue Share, by Product 2022 & 2030 (%)

Figure 6. Spinal Cord Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 7. Deep Brain Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 8. Sacral Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 9. Vagus Nerve Stimulator: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 10. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 11. Asia Pacific Neurostimulation Devices Market Revenue Share, by Application 2022 & 2030 (%)

Figure 12. Pain Management: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 13. Epilepsy: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 14. Urinary and Fecal Incontinence: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 15. Parkinson's Disease: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 16. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 17. Asia Pacific Neurostimulation Devices Market Revenue Share, by End User 2022 & 2030 (%)

Figure 18. Hospitals & Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 19. Specialty Clinics: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 20. Others: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 21. Asia Pacific: Neurostimulation Devices Market, by Key Country - Revenue (2022) (US$ Million)

Figure 22. Asia Pacific: Neurostimulation Devices Market, by Country, 2022 & 2030 (%)

Figure 23. China: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 24. Japan: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 25. India: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 26. Australia: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 27. South Korea: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

Figure 28. Rest of Asia Pacific: Neurostimulation Devices Market - Revenue and Forecast to 2030 (US$ Million)

1. Medtronic Plc

2. Boston Scientific Corp

3. Abbott Laboratories

4. Nevro Corp

5. LivaNova Plc

6. Mainstay Medical

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific neurostimulation devices market.

Highlights key business priorities in order to assist companies to realign their business strategies

The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific neurostimulation devices market, thereby allowing players across the value chain to develop effective long-term strategies

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific neurostimulation devices market, as well as those hindering it

Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3550

$2840

Site License

$4550

$3640

Enterprise License

$5550

$4440

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Get Free Sample For Asia Pacific Neurostimulation Devices Market

WHAT'S INCLUDED IN FULL REPORT